Livzon Pharmaceutical Group Inc.
000513
Rang în acțiuni
#4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
Preț acțiune
$3.90
Capitalizare de piață
$3.17B
Schimbare (1 zi)
-3.49%
Schimbare (1 an)
-25.88%
Țară
CN
Tranzacționează Livzon Pharmaceutical Group Inc. (000513)
Categorie
Healthcare
EPS pentru Livzon Pharmaceutical Group Inc. (000513)
EPS la data de June 2026 TTM: $0.28
Conform celor mai recente rapoarte financiare și prețului acțiunilor Livzon Pharmaceutical Group Inc., EPS-ul actual al companiei (TTM) este $0.28. La sfârșitul anului 2024, compania avea un EPS de $0.31 o creștere față de EPS-ului din 2023, care a fost de $0.30.
Istoricul EPS pentru Livzon Pharmaceutical Group Inc. din 2001 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $0.28 | -11.56% |
| 2025 | $0.32 | 5.73% |
| 2024 | $0.31 | 3.44% |
| 2023 | $0.30 | 0.34% |
| 2022 | $0.30 | -1.07% |
| 2021 | $0.30 | 6.71% |
| 2020 | $0.28 | 40.33% |
| 2019 | $0.20 | 18.39% |
| 2018 | $0.17 | -77.05% |
| 2017 | $0.73 | 466.90% |
| 2016 | $0.13 | 13.68% |
| 2015 | $0.11 | 15.74% |
| 2014 | $0.10 | 3.03% |
| 2013 | $0.10 | 14.63% |
| 2012 | $0.08 | 22.29% |
| 2011 | $0.07 | -10.03% |
| 2010 | $0.08 | -7.56% |
| 2009 | $0.08 | 842.53% |
| 2008 | $0.01 | -89.04% |
| 2007 | $0.08 | 195.17% |
| 2006 | $0.03 | 80.54% |
| 2005 | $0.01 | -11.83% |
| 2004 | $0.02 | 7.64% |
| 2003 | $0.02 | 45.37% |
| 2002 | $0.01 | 27.06% |
| 2001 | $0.01 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $6.55 | 2,213.50% |
DE
|
|
| $6.12 | 2,062.69% |
DE
|
|
| $0.72 | 155.51% |
JP
|
|
| $3.66 | 1,193.29% |
CH
|
|
| $0.53 | 88.59% |
IN
|
